K. Thiongo

Efficacy of artemisinin–lumefantrine for treatment of uncomplicated malaria after more than a decade of its use in Kenya

D. Matoke-Muhia, F. Kimani, E. Njagi, 2020, Epidemiology and Infection.

S0950268820003167jra 1..9

D. Matoke-Muhia, F. Kimani, E. Njagi, 2021 .

Efficacy of Artemisinin-lumefantrine for the treatment of uncomplicated malaria after more than a decade after its use in Kenya

D. Matoke-Muhia, F. Kimani, E. Njagi, 2020 .

Clinical efficacy of artemisinin-lumefantrine and status of antifolate drug resistance markers in western Kenya

D. Matoke-Muhia, F. Kimani, E. Njagi, 2019 .

The genomic epidemiology of SARS-CoV-2 variants of concern in Kenya

A. Rambaut, M. Cotten, C. Agoti, 2022, medRxiv.

Molecular monitoring of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in western Kenya, 14 years after its withdrawal

F. Kimani, E. Njagi, D. Muhia, 2019 .